Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (71-80 of 308) with videos related to

Pageof 31
Sort By:
Current Opinion in Allergy and Clinical Immunology|October 24, 2012
Adjuvants for immunotherapyOliver Pfaar, Dorotheea Cazan, Ludger Klimek, et al.
Dermatology (Basel, Switzerland)|January 26, 2021
Effects of Patients' Expectation in Dermatology: Evidence from Experimental and Clinical Placebo Studies and Implications for Dermatologic Practice and ResearchWiebke Sondermann, Finja Reinboldt-Jockenhöfer, Joachim Dissemond, et al.
Laryngo- Rhino- Otologie|November 3, 2025
[Insect Venom Allergy 2025 - What should ENT Specialists know?]Sophie Cathrine Hermann, Stijn Bogaert, Alexander Nastev, et al.
Allergy|March 10, 2025
Comparative Evaluation of an Allergen Exposure Chamber and Nasal Allergen Challenge Versus In-Field Symptom Assessment in Patients With Allergic Rhinitis Triggered by Timothy Grass PollenMagdalena Zemelka-Wiacek, Anna Kosowska, Oliver Pfaar, et al.
Biomed Research International|September 10, 2015
Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter StudyOliver Pfaar, Heinz-Gerd Richter, Ludger Klimek, et al.
Clinical and Translational Allergy|September 2, 2015
Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trialLudger Klimek, Claus Bachert, Karl-Friedrich Lukat, et al.
The World Allergy Organization Journal|May 30, 2023
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023Oliver Pfaar, Sven Becker, Christopher Calabria, et al.
Allergy|October 24, 2024
Improved quality control of allergen products: Assessing the molecular allergen composition by mass spectrometrySteffen Augustin, Thomas Eichhorn, Martin Wald, et al.
Clinical and Translational Allergy|July 25, 2023
Barrier-forming, drug-free nasal spray reduces allergic symptoms induced by house dust mite allergenPatricia Couroux, Nicole Grosse, Anne Marie Salapatek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2021
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the FutureOliver Pfaar, Peter S Creticos, Jörg Kleine-Tebbe, et al.
Pageof 31

Showing results (71-80 of 308) with videos related to

Sort By:
Pageof 31
Current Opinion in Allergy and Clinical Immunology|October 24, 2012
Adjuvants for immunotherapyOliver Pfaar, Dorotheea Cazan, Ludger Klimek, et al.
Dermatology (Basel, Switzerland)|January 26, 2021
Effects of Patients' Expectation in Dermatology: Evidence from Experimental and Clinical Placebo Studies and Implications for Dermatologic Practice and ResearchWiebke Sondermann, Finja Reinboldt-Jockenhöfer, Joachim Dissemond, et al.
Laryngo- Rhino- Otologie|November 3, 2025
[Insect Venom Allergy 2025 - What should ENT Specialists know?]Sophie Cathrine Hermann, Stijn Bogaert, Alexander Nastev, et al.
Allergy|March 10, 2025
Comparative Evaluation of an Allergen Exposure Chamber and Nasal Allergen Challenge Versus In-Field Symptom Assessment in Patients With Allergic Rhinitis Triggered by Timothy Grass PollenMagdalena Zemelka-Wiacek, Anna Kosowska, Oliver Pfaar, et al.
Biomed Research International|September 10, 2015
Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter StudyOliver Pfaar, Heinz-Gerd Richter, Ludger Klimek, et al.
Clinical and Translational Allergy|September 2, 2015
Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trialLudger Klimek, Claus Bachert, Karl-Friedrich Lukat, et al.
The World Allergy Organization Journal|May 30, 2023
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023Oliver Pfaar, Sven Becker, Christopher Calabria, et al.
Allergy|October 24, 2024
Improved quality control of allergen products: Assessing the molecular allergen composition by mass spectrometrySteffen Augustin, Thomas Eichhorn, Martin Wald, et al.
Clinical and Translational Allergy|July 25, 2023
Barrier-forming, drug-free nasal spray reduces allergic symptoms induced by house dust mite allergenPatricia Couroux, Nicole Grosse, Anne Marie Salapatek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2021
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the FutureOliver Pfaar, Peter S Creticos, Jörg Kleine-Tebbe, et al.
Pageof 31